Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
Phase 1/2 Completed
34 enrolled 13 charts
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Phase 1/2 Completed
214 enrolled
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
Phase 1/2 Completed
341 enrolled 28 charts
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
332 enrolled 44 charts
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
31 enrolled 20 charts
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Phase 1/2 Completed
64 enrolled 20 charts
CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
Phase 1/2 Completed
49 enrolled
Carac & PDT Combination in the Treatment Of Actinic Keratoses
Phase 1/2 Completed
60 enrolled
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
Phase 1/2 Completed
73 enrolled 18 charts
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer
Phase 1/2 Completed
126 enrolled 19 charts
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
Phase 1/2 Completed
495 enrolled 18 charts
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
Phase 1/2 Completed
213 enrolled 42 charts
A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors
Phase 1/2 Completed
40 enrolled
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Phase 1/2 Completed
70 enrolled 17 charts
DEBIRI
Phase 1/2 Completed
70 enrolled 10 charts
Trimodality Management of T1b Esophageal Cancers
Phase 1/2 Completed
4 enrolled 8 charts
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Phase 1/2 Completed
50 enrolled
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
Phase 1/2 Completed
59 enrolled 16 charts
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase 1/2 Completed
7 enrolled
ASN-002-001
Phase 1/2 Completed
16 enrolled
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
Phase 1/2 Completed
25 enrolled 7 charts
Study of Adjuvant Radiochemotherapy for Gastric Cancer
Phase 1/2 Completed
65 enrolled
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
Phase 1/2 Completed
32 enrolled 14 charts
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
Phase 1/2 Completed
36 enrolled
Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
Phase 1/2 Completed
49 enrolled 12 charts
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
Phase 1/2 Completed
98 enrolled 8 charts
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Phase 1/2 Completed
60 enrolled
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
33 enrolled
Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
Phase 1/2 Completed
36 enrolled
ADVANTAGE
Phase 1/2 Completed
184 enrolled 20 charts
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
Phase 1/2 Completed
172 enrolled 12 charts
Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
Phase 1/2 Completed
35 enrolled
Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer
Phase 1/2 Completed
84 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
Phase 1/2 Completed
Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer
Phase 1/2 Completed
60 enrolled
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 1/2 Completed
Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery
Phase 1/2 Completed
Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)
Phase 1/2 Completed
Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
Phase 1/2 Completed
24 enrolled
Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer
Phase 1/2 Completed
60 enrolled 12 charts
Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer
Phase 1/2 Completed
16 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
Phase 1/2 Completed
26 enrolled
Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
Phase 1/2 Completed
48 enrolled
Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer
Phase 1/2 Completed
Stage IV Colorectal CA ALIMTA
Phase 1/2 Completed
200 enrolled
SILIUS
Phase 1/2 Completed
37 enrolled
Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.
Phase 1/2 Completed
30 enrolled
Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.
Phase 1/2 Completed
30 enrolled
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Completed
38 enrolled
Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer
Phase 1/2 Completed
23 enrolled